|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang C: Novel functions for small RNA
molecules. Curr Opin Mol Ther. 11:641–651. 2009.
|
|
6
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsai MM, Wang CS, Tsai CY, Huang HW, Chi
HC, Lin YH, Lu PH and Lin KH: Potential diagnostic, prognostic and
therapeutic targets of MicroRNAs in human gastric cancer. Int J Mol
Sci. 17:172016. View Article : Google Scholar
|
|
9
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ota A, Tagawa H, Karnan S, Tsuzuki S,
Karpas A, Kira S, Yoshida Y and Seto M: Identification and
characterization of a novel gene, C13orf25, as a target for
13q31-q32 amplification in malignant lymphoma. Cancer Res.
64:3087–3095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92 is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farazi TA, Horlings HM, Ten Hoeve JJ,
Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F,
van Kouwenhove M, et al: MicroRNA sequence and expression analysis
in breast tumors by deep sequencing. Cancer Res. 71:4443–4453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chow TF, Mankaruos M, Scorilas A, Youssef
Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et
al: The miR-17-92 cluster is over expressed in and has an oncogenic
effect on renal cell carcinoma. J Urol. 183:743–751. 2010.
View Article : Google Scholar
|
|
14
|
Zhu H, Han C and Wu T: MiR-17-92 cluster
promotes hepatocarcinogenesis. Carcinogenesis. 36:1213–1222. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu G, Tang JQ, Tian ML, Li H, Wang X, Wu
T, Zhu J, Huang SJ and Wan YL: Prognostic values of the miR-17-92
cluster and its paralogs in colon cancer. J Surg Oncol.
106:232–237. 2012. View Article : Google Scholar
|
|
16
|
Li H, Wu Q, Li T, Liu C, Xue L, Ding J,
Shi Y and Fan D: The miR-17-92 cluster as a potential biomarker for
the early diagnosis of gastric cancer: Evidence and literature
review. Oncotarget. 8:45060–45071. 2017.PubMed/NCBI
|
|
17
|
Mogilyansky E and Rigoutsos I: The
miR-17/92 cluster: A comprehensive update on its genomics,
genetics, functions and increasingly important and numerous roles
in health and disease. Cell Death Differ. 20:1603–1614. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valladares-Ayerbes M, Blanco M, Haz M,
Medina V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Reboredo M,
Santamarina I, Figueroa A, Antón-Aparicio LM, et al: Prognostic
impact of disseminated tumor cells and microRNA-17-92 cluster
deregulation in gastrointestinal cancer. Int J Oncol. 39:1253–1264.
2011.PubMed/NCBI
|
|
19
|
Ren C, Wang W, Han C, Chen H, Fu D, Luo Y,
Yao H, Wang D, Ma L, Zhou L, et al: Expression and prognostic value
of miR-92a in patients with gastric cancer. Tumour Biol.
37:9483–9491. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsujiura M, Komatsu S, Ichikawa D,
Shiozaki A, Konishi H, Takeshita H, Moriumura R, Nagata H,
Kawaguchi T, Hirajima S, et al: Circulating miR-18a in plasma
contributes to cancer detection and monitoring in patients with
gastric cancer. Gastric Cancer. 18:271–279. 2015. View Article : Google Scholar
|
|
21
|
Wu Q, Luo G, Yang Z, Zhu F, An Y, Shi Y
and Fan D: miR-17-5p promotes proliferation by targeting SOCS6 in
gastric cancer cells. FEBS Lett. 588:2055–2062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park D, Lee SC, Park JW, Cho SY and Kim
HK: Overexpression of miR-17 in gastric cancer is correlated with
proliferation-associated oncogene amplification. Pathol Int.
64:309–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu W, Takanashi M, Borjigin N, Ohno SI,
Fujita K, Hoshino S, Osaka Y, Tsuchida A and Kuroda M: MicroRNA-18a
modulates STAT3 activity through negative regulation of PIAS3
during gastric adenocarcinogenesis. Br J Cancer. 108:653–661. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang F, Li T, Zhang B, Li H, Wu Q, Yang L,
Nie Y, Wu K, Shi Y and Fan D: MicroRNA-19a/b regulates multidrug
resistance in human gastric cancer cells by targeting PTEN. Biochem
Biophys Res Commun. 434:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu Q, Yang Z, Wang F, Hu S, Yang L, Shi Y
and Fan D: MiR-19b/20a/92a regulates the self-renewal and
proliferation of gastric cancer stem cells. J Cell Sci.
126:4220–4229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu F, Zhou J, Zhou P, Chen W and Guo F:
The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs
the ability of migration and invasion in gastric cancer cells. Int
J Oncol. 46:2096–2106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou P, Ma L, Zhou J, Jiang M, Rao E, Zhao
Y and Guo F: miR-17-92 plays an oncogenic role and conveys
chemo-resistance to cisplatin in human prostate cancer cells. Int J
Oncol. 48:1737–1748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu J, Zhou P, Wang W, Sun A and Guo F:
RelB, together with RelA, sustains cell survival and confers
proteasome inhibitor sensitivity of chronic lymphocytic leukemia
cells from bone marrow. J Mol Med (Berl). 92:77–92. 2014.
View Article : Google Scholar
|
|
31
|
Li L, Shi B, Chen J, Li C, Wang S, Wang Z
and Zhu G: An E2F1/MiR-17-92 Negative Feedback Loop mediates
proliferation of Mouse Palatal Mesenchymal Cells. Sci Rep.
7:51482017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li L, Song W, Yan X, Li A, Zhang X, Li W,
Wen X, Zhou L, Yu D, Hu JF, et al: Friend leukemia virus
integration 1 promotes tumorigenesis of small cell lung cancer
cells by activating the miR-17-92 pathway. Oncotarget.
8:41975–41987. 2017.PubMed/NCBI
|
|
33
|
Chen Y, Tian L, Wan S, Xie Y, Chen X, Ji
X, Zhao Q, Wang C, Zhang K, Hock JM, et al: MicroRNA-17-92 cluster
regulates pancreatic beta-cell proliferation and adaptation. Mol
Cell Endocrinol. 437:213–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou J, Jiang J, Wang S and Xia X:
Oncogenic role of microRNA 20a in human uveal melanoma. Mol Med
Rep. 14:1560–1566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Lei C, Fan J and Wang J: miR-18a
promotes cell proliferation of esophageal squamous cell carcinoma
cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR
signaling axis. Biochem Biophys Res Commun. 477:144–149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Deutzmann A, Choi PS, Fan AC and
Felsher DW: BIM mediates oncogene inactivation-induced apoptosis in
multiple transgenic mouse models of acute lymphoblastic leukemia.
Oncotarget. 7:26926–26934. 2016.PubMed/NCBI
|
|
37
|
Gupta S, Read DE, Deepti A, Cawley K,
Gupta A, Oommen D, Verfaillie T, Matus S, Smith MA, Mott JL, et al:
Perk-dependent repression of miR-106b-25 cluster is required for ER
stress-induced apoptosis. Cell Death Dis. 3:e3332012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang X, Chen Y, Zhao P, Zang L, Zhang Z
and Wang X: MicroRNA-19a functions as an oncogene by regulating
PTEN/ AKT/pAKT pathway in myeloma. Leuk Lymphoma. 58:932–940. 2017.
View Article : Google Scholar
|
|
39
|
Jia Q, Sun H, Xiao F, Sai Y, Li Q, Zhang
X, Yang S, Wang H, Wang H, Yang Y, et al: miR-17-92 promotes
leukemogenesis in chronic myeloid leukemia via targeting A20 and
activation of NF-κB signaling. Biochem Biophys Res Commun.
487:868–874. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Trenkmann M, Brock M, Gay RE, Michel BA,
Gay S and Huber LC: Tumor necrosis factor α-induced microRNA-18a
activates rheumatoid arthritis synovial fibroblasts through a
feedback loop in NF-κB signaling. Arthritis Rheum. 65:916–927.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jin HY, Oda H, Lai M, Skalsky RL, Bethel
K, Shepherd J, Kang SG, Liu WH, Sabouri-Ghomi M, Cullen BR, et al:
MicroRNA-17~92 plays a causative role in lymphomagenesis by
coordinating multiple oncogenic pathways. EMBO J. 32:2377–2391.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Quattrochi B, Gulvady A, Driscoll DR, Sano
M, Klimstra DS, Turner CE and Lewis BC: MicroRNAs of the mir-17~92
cluster regulate multiple aspects of pancreatic tumor development
and progression. Oncotarget. 8:35902–35918. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cohen R, Greenberg E, Nemlich Y, Schachter
J and Markel G: miR-17 regulates melanoma cell motility by
inhibiting the translation of ETV1. Oncotarget. 6:19006–19016.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Yang S, Yan W, Yang J, Qin YJ, Lin
XL, Xie RY, Wang SC, Jin W, Gao F, et al: MicroRNA-19 triggers
epithelial-mesenchymal transition of lung cancer cells accompanied
by growth inhibition. Lab Invest. 95:1056–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bahari F, Emadi-Baygi M and Nikpour P:
miR-17-92 host gene, uderexpressed in gastric cancer and its
expression was negatively correlated with the metastasis. Indian J
Cancer. 52:22–25. 2015. View Article : Google Scholar
|
|
46
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gilmore TD: Introduction to NF-kappaB:
Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
He JQ, Oganesyan G, Saha SK, Zarnegar B
and Cheng G: TRAF3 and its biological function. Adv Exp Med Biol.
597:48–59. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Arch RH, Gedrich RW and Thompson CB: Tumor
necrosis factor receptor-associated factors (TRAFs)--a family of
adapter proteins that regulates life and death. Genes Dev.
12:2821–2830. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liao G, Zhang M, Harhaj EW and Sun SC:
Regulation of the NF-kappaB-inducing kinase by tumor necrosis
factor receptor-associated factor 3-induced degradation. J Biol
Chem. 279:26243–26250. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Asano N, Imatani A, Watanabe T, Fushiya J,
Kondo Y, Jin X, Ara N, Uno K, Iijima K, Koike T, et al: Cdx2
expression and intestinal metaplasia induced by H. pylori infection
of gastric cells is regulated by NOD1-mediatedinnate immune
responses. Cancer Res. 76:1135–1145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Malcomson FC, Willis ND, McCallum I, Xie
L, Lagerwaard B, Kelly S, Bradburn DM, Belshaw NJ, Johnson IT and
Mathers JC: Non-digestible carbohydrates supplementation increases
miR-32 expression in the healthy human colorectal epithelium: A
randomized controlled trial. Mol Carcinog. 56:2104–2111. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu J, Li D, Dang L, Liang C, Guo B, Lu C,
He X, Cheung HY, He B, Liu B, et al: Osteoclastic miR-214 targets
TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Sci Rep. 7:404872017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fang Y, Chen H, Hu Y, Li Q, Hu Z, Ma T and
Mao X: Burkholderia pseudomallei-derived miR-3473 enhances NF-κB
via targeting TRAF3 and is associated with different inflammatory
responses compared to Burkholderia thailandensis in murine
macrophages. BMC Microbiol. 16:2832016. View Article : Google Scholar
|
|
55
|
Zou M, Wang F, Jiang A, Xia A, Kong S,
Gong C, Zhu M, Zhou X, Zhu J, Zhu W, et al: MicroRNA-3178
ameliorates inflammation and gastric carcinogenesis promoted by
Helicobacter pylori new toxin, Tip-α, by targeting TRAF3.
Helicobacter. 22:222017. View Article : Google Scholar
|
|
56
|
Gu H, Yu J, Dong D, Zhou Q, Wang JY and
Yang P: The miR-322-TRAF3 circuit mediates the pro-apoptotic effect
of high glucose on neural stem cells. Toxicol Sci. 144:186–196.
2015. View Article : Google Scholar :
|
|
57
|
Yarbrough ML, Zhang K, Sakthivel R, Forst
CV, Posner BA, Barber GN, White MA and Fontoura BM:
Primate-specific miR-576-3p sets host defense signalling threshold.
Nat Commun. 5:49632014. View Article : Google Scholar : PubMed/NCBI
|
